J&J does Alzheimer's gene therapy deal, along with 14 other new collaborations
Johnson & Johnson has inked a research deal with University of Pennsylvania to work on gene therapy for Alzheimer’s. The partnership leverages the university’s adeno …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.